You are here

Home ยป Company Details

ONCOFACTOR CORPORATION

Company Information
Address
1616 EASTLAKE AVE E STE. 200
SEATTLE, WA 98102-3788
United States
Information

UEI: N/A

# of Employees: 4
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 1

  1. Treatment of non-small cell lung cancer with a CCL14 monoclonal antibody

    Amount: $220,191.00

    DESCRIPTION (provided by applicant): Lung cancer is the most prevalent cancer worldwide and responsible for the most cancer deaths in the United States. Existing therapies include surgery, radiation, ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government